This educational program consists of three presentations on optimizing RAASi therapy in patients with heart failure.

This course consists of the following:

• Guidelines, RAASi and hyperkalemia: the clinical dilemmas in heart failure - Prof. Andrew Coats, MD - Coventry, UK
• Hyperkalemia in heart failure: Why should we care? - Clara Bonanad Lozano, MD, PhD - Valencia, Spain
• Potassium binding as RAASi enabling therapy: applying recent insights into practice - Aaron Wong, MD - Bridgend, UK

How to obtain your CME certificate

• Watch the three lectures and answer the pre- and post-test questions
• Fill in the evaluation questions
• Download CME Certificate (if your score >70%)

After watching these three videos, the learner should be able to:

• Understand the impact and significance of long-term RAASi treatment, at maximum tolerated guideline recommended doses in HF patients
• Discuss the clinical dilemma with regard to hyperkalemia in patients with heart failure
• Discuss new directions in hyperkalemia management that could achieve better outcomes in HF patients

Expert faculty

• Prof. Andrew Coats, MD - Coventry, UK
• Clara Bonanad Lozano, MD, PhD - Valencia, Spain
• Aaron Wong, MD - Bridgend, UK

Target audience

This educational activity is designed for all healthcare professionals with an interest in management of patients with heart failure.

CME accreditation

This online course is accredited by the European Board for Accreditation of Continuing Education for Health Professionals (EBAC) for 1 hour of external CME credit.

Through an agreement between EBAC and the American Medical Association, physicians may convert EBAC External CME credits to AMA PRA Category 1 Credits™. Information on the process to convert EBAC credit to AMA credit can be found on the AMA website. Other health care professionals may obtain from the AMA a certificate of having participated in an activity eligible for conversion of credit to AMA PRA Category 1 Credit™.

Funding

Funding for this educational program was provided by an unrestricted educational grant from AstraZeneca.

Questions

For questions regarding this activity, please contact us at info@pace-cme.org.